Last mentioned: 9h ago
Across the most recent 20 stories covering Wall Street Zen — 100% neutral sentiment, averaging 5/10 impact.
This entity profile aggregates every story where the entity meets our minimum relevance threshold before it is linked here — a story naming this entity only in passing, as competitive context for an unrelated subject, does not qualify. That threshold exists because earlier testing surfaced entity pages cluttered with tangential mentions: a story about two unrelated companies merging could otherwise populate a third company's page simply because it was named once for comparison, with no real event of its own. The timeline below reflects genuine milestones and developments specific to this entity, cross-referenced against the same source-verification standard applied to every story on this site. Sentiment measures the directional read of each development for this entity specifically, not the overall tone of the reporting, and impact weights how consequential a development is rather than how widely it was syndicated across outlets.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Dividend payment
The $0.36 quarterly dividend is paid to shareholders of record as of August 17.
Ex-dividend date
Middlesex Water's quarterly dividend of $0.36 goes ex-dividend.
Baird price target and stock rebound
Robert W. Baird set a $66.00 price target; the stock traded up to $57.60, rising $1.79.
Q2 2026 earnings release
Middlesex Water reported Q2 EPS of $0.79 on revenue of $56.36 million; shares closed at $55.81, down $1.44.
Quarterly earnings released
SMBC reports EPS of $1.83 vs. $1.52 estimate, revenue of $51.77M.
Weiss Ratings downgrade
Weiss Ratings cut Middlesex Water from 'hold (c)' to 'hold (c-)'.
New Street Research target
New Street Research set a $64.00 price target on Middlesex Water.
Piper Sandler adjusts PT
Piper Sandler reiterates Neutral, boosts target from $71 to $79.
Three directors execute insider purchases
Philip Fracassa buys 5,000 MBC shares, Paul Koonce buys 500 SR shares, and Frederick Disanto buys 1,000 EML shares, all in open-market transactions.
Insider sale by EVP Windes
EVP Richard Windes sells 2,000 shares at average $69.70, totaling $139,400.
Weiss Ratings reiterates Buy
Weiss Ratings issues a 'buy (b)' rating on SMBC.
Eastern reports Q1 2026 earnings
EML delivers $0.11 EPS, missing the $0.50 estimate by $0.39; revenue of $59.68M trails the $67.74M consensus.
Wall Street Zen upgrade
Wall Street Zen upgraded Middlesex Water from 'sell' to 'hold'.
Spire reports Q2 2026 earnings
SR earns $3.76 per share, topping analyst expectations of $3.72 by $0.04; revenue of $1.02B misses consensus by $50M.
Stephens bullish call
Stephens reiterates Overweight rating, lifts PT to $76 from $72.
RBC downgrades Eastern to Hold
Royal Bank of Canada cuts EML from Moderate Buy to Hold, likely after earnings miss.
KBW target price increase
Keefe, Bruyette & Woods raises price target from $64 to $65, maintaining Market Perform rating.
Sentiment Review
Major analysts maintain existing price targets and ratings despite the earnings beat.
Wall Street Zen Downgrade
Official rating cut to Hold for both TEAM and ON tickers.
Market Warnings
Analysts warn of a 'chaos tsunami' in the workforce due to rapid AI integration at tech firms.
BARK delivered a surprise $0.08 EPS, beating estimates by $0.48, sending its battered stock up to $11.25. With a $101.6M market cap and a consensus target of $15.33, the high-beta small-cap is drawing both institutional and retail interest.
Source: themarketsdaily.com · dailypolitical.com
Astronics Corporation's share price vaulted 7.8% on June 11, 2026, to $88.76, with analysts split between a $100 high target and a sell rating. The company's 6-for-5 stock split, effective June 15, adds to the excitement, but low volume and high P/E warrant caution for value investors.
Source: tickerreport.com · dailypolitical.com
HC Wainwright and Needham lowered price targets on Circle Internet Group but maintained Buy ratings as analysts remain split on the stablecoin issuer. The stock trades at $63.48, far below the consensus target of $100.06, highlighting both opportunity and risk.
In a single day, Wall Street Zen downgraded CME Group to strong sell, and Novavax and SNDL to sell, sending bearish signals across exchanges, biotech, and cannabis. Markets digest the calls amid wide analyst disagreement.
Middlesex Water's Q2 EPS of $0.79 surged past estimates, reinforcing its reputation as a stable income play. With a 2.5% yield and 60% payout ratio, the utility delivered strong net margins of 22.07%. However, mixed analyst ratings and a beta of 0.78 suggest cautious optimism.
Source: MarketBeat · dailypolitical.com
Southern Missouri Bancorp delivered a strong quarter with earnings of $1.83 per share, beating estimates by $0.31 on revenue of $51.77 million. However, the stock fell 1.4% to $75.41 as analysts remain divided and insider selling raises questions.
Source: MarketBeat · tickerreport.com
Pentair’s revised Q2 2026 guidance stunned investors, with EPS of $1.12 against a $1.48 estimate and revenue of $930M, well below the $1.1B consensus. The stock slid to $75.74 on heavy volume, its 200-day MA, and the new full-year EPS range of $4.60-4.80 implies a 10-14% miss, triggering a fresh round of analyst target cuts.
Source: MarketBeat · MarketBeat
Aehr Test Systems reported Q4 earnings of $0.05 per share, beating the consensus estimate of -$0.01 by $0.06. Despite negative net margins of -25.23% and insider selling, shares surged 5.9% to $72.01, with analysts mixed — two buys, one hold, one sell, and a Hold consensus with a $68 target.
Source: MarketBeat · tickerreport.com
Three corporate directors executed open-market purchases totaling $106,030 on June 11, signaling potential undervaluation at Eastern, Spire, and MasterBrand. The buys ranged from a 0.99% stake boost at Eastern to a 12.49% jump at MasterBrand, despite mixed earnings and sell-side downgrades.
Source: InsiderTrades com · InsiderTrades com
Codexis reported a significant Q4 2025 earnings beat, driven by its ECO Synthesis platform and expanding CDMO partnerships. Despite a raised 2026 revenue outlook and a surprise GAAP profit, analyst sentiment remains largely unchanged as the market awaits further commercial validation of its RNA manufacturing technology.
Wall Street Zen has lowered its ratings for Atlassian and ON Semiconductor to 'Hold,' reflecting a cooling sentiment toward high-growth tech and semiconductor leaders. The move comes as Atlassian navigates AI-driven restructuring and ON Semiconductor faces a maturing cycle in the automotive chip market.
Source: themarketsdaily.com · themarketsdaily.com
Wall Street Zen has issued 'Sell' ratings for both SAB Biotherapeutics and SURO Capital, signaling a shift in sentiment for high-risk biotech and venture-backed assets. These downgrades reflect growing analyst caution regarding clinical-stage development timelines and private equity valuation gaps in the 2026 market environment.
Alignment Healthcare's President and another insider divested over 33,000 shares in mid-March, following a massive secondary offering and a rating downgrade. The sales come as the Medicare Advantage provider reports narrowing losses but faces a shift in analyst sentiment from 'Buy' to 'Hold.'
Investment research platform Wall Street Zen has lowered its ratings for footwear distributor Weyco Group and home services provider Frontdoor to 'Hold.' The shift reflects a more cautious outlook on consumer discretionary spending and the housing-adjacent service sector as both companies face evolving market conditions.
Source: dailypolitical.com · dailypolitical.com
Investment research platform Wall Street Zen has issued dual upgrades for regional lender Lakeland Financial and networking firm ADTRAN. The ratings shift follows a significant earnings beat by ADTRAN and a stabilizing outlook for Indiana-based Lakeland Financial.
Source: tickerreport.com · tickerreport.com
Wall Street Zen has lowered its investment ratings for Alignment Healthcare and Freshworks from Buy to Hold, signaling a shift to a neutral outlook. The downgrades reflect a cautious stance on the Medicare Advantage sector and the competitive SaaS landscape as both companies navigate evolving market dynamics in early 2026.
Wall Street Zen has issued a series of ratings downgrades targeting a diverse group of companies including NanoVibronix, Cellebrite, MicroVision, and The Honest Company. These moves signal a shift in sentiment toward high-growth and speculative tech sectors as analysts re-evaluate valuation and performance metrics.
Wall Street Zen has lowered its ratings for luxury fashion house Tapestry and foodservice giant Sysco, signaling a more cautious stance on these sector leaders. The adjustments reflect shifting valuation dynamics and macroeconomic headwinds facing the consumer discretionary and staples sectors.
Source: dailypolitical.com · tickerreport.com
Analyst firm Wall Street Zen has issued significant rating upgrades for Weatherford International, Docebo, and Organogenesis. These shifts to 'Buy' and 'Strong-Buy' status signal a positive fundamental outlook across the energy, enterprise software, and healthcare sectors.
Wall Street Zen has downgraded both electronic manufacturing services provider Plexus (PLXS) and family safety platform Life360 (LIF) to Hold ratings. These shifts reflect a cautious stance on mid-cap growth and industrial tech as investors weigh valuation against near-term execution risks.
Source: defenseworld.net · defenseworld.net
This page surfaces every story mentioning Wall Street Zen across our finance coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running finance beat. Cross-entity comparisons live on our compare view.
Entities only appear on this page once the classifier scores them at a minimum 35 percent relevance to the story, filtering out passing mentions. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Wall Street Zen was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |